Ashino et al. [54] have proven that the selective inhibition of JAK1/3 reduced STAT6 and STAT5 phosphorylation and Th2 cytokine production, which suppressed the development of airway hyperresponsiveness. The gene discussed is STAT6; the disease is airway hyperresponsiveness.